Skip to main content
. 2022 Jan 13;73(7):2251–2262. doi: 10.1093/jxb/erac008

Fig. 6.

Fig. 6.

Glufosinate in vitro inhibition of glutamine synthetase (GS) activity of (A) purified yeast recombinant EiGS1-1-WT and EiGS1-1-R59 proteins and (B) in leaf extracts of glufosinate-susceptible (EiGS-S) and -resistant (EiGS-R) E. indica. Data are means ±SE of three biological replicates per treatment for EiGS-S and EiGS-R samples, and three technical replicates for yeast recombinant EiGS1-1 samples.